2m 2m 2m 2m 2m 2m 2m
Neurocrine Biosc (NBIX)
NASDAQ
$166.40-$0.40 (-0.24%)
Price as of Aug 03, 2026 4:45 AM EDT- $16.8BMarket Cap
- 29.39%1-Year Change
- Drug Manufacturers - Specialty & GenericIndustry
Neurocrine Biosc (NBIX)
$166.40-$0.40 (-0.24%)
NBIX | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $166.80 | ||
Change | -$18.70 (-10.08%) | ||
Open | $184.34 | ||
High | $185.55 | ||
Low | $164.56 | ||
Previous Close | $185.50 | ||
Volume | 4,591,009 | ||
30-Day Average Volume | 1,307,128 | ||
1-Week Change | -5.10% | ||
1-Month Change | -1.03% | ||
1-Year Change | 29.39% | ||
3-Year Change | 63.71% | ||
5-Year Change | 78.95% | ||
Fundamentals | |||
Shares Outstanding | 100.5M | ||
Total Assets | $5.4B | ||
Market Cap | $16.8B | ||
Enterprise Value | $16.4B | ||
Period: QTR TTM FY | |||
Revenue | $954.3M | ||
Net Income | $144.4M | ||
Free Cash Flow | $128.6M | ||
EBIT | $165.1M | ||
EBITDA | $181.5M | ||
Net Working Capital | $763.0M | ||
EPS | $1.39 | ||
Enterprise Value/EBITDA | 91 | ||
Enterprise Value/Revenue | 17 | ||
P/B | 5 | ||
P/E | 120 | ||
PEG | -4 | ||
Price/Free Cash Flow | 130 | ||
Price/Operating Cash Flow | 123 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue